VIEW ARTICLES Macular Degeneration a Key Topic for Retinal Specialists Dosimetry Characterization of a Multibeam Radiotherapy Treatment for Age-Related Macular Degeneration

Developing noninvasive robotically controlled treatments for inflammatory and neovascular diseases of the eye. Oraya Therapeutics is currently testing its first application of the IRay™ system. ABOUT ORAYA   OUR TEAM   CLINICAL TRIALS Dedicated to developing noninvasive therapies for diseases of the eye. Leadership in producing innovative medical technologies. In progress.

Copyright © 2009 Oraya Therapeutics, Inc. All rights reserved. | (510) 456-3700 | info@orayainc.com
Note: IRay™ is an investigational device. Limited by Federal (U.S.A.) law to investigational use.